#Genes2Me

[pathologylab]

Join us in celebrating #InternationalWomensDay 2024! This year's theme is 'Inspire Inclusion,' emphasizing the importance of empowering and including #women from all walks of life. We at #G2M honour the achievements, resilience, strength, power, intelligence, and contributions of women worldwide. Together, we can inspire inclusion, break barriers, and create a more equitable future for all. #Happy International #WomensDay!

#IWD2024 #InspireInclusion #WomenEmpowerment #womensday2024 #happywomensday #genes2me #healthcareindustry #healthcare #internationalwomensday2024 #internationalwomensmonth

[bharatlivenewsmedia]

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit

Cipla inks pact with Genes2Me to launch COVID-19 RT PCR test kit With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory filing. With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding its diagnostics offerings, it said in a regulatory…

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.

[social-mania]

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

Cipla partners with Genes2Me to launch Coronavirus RT PCR test kit

The kit is validated by the Indian Council of Medical Research (ICMR) and much more advanced than other RT PCR tests, the drug firm said Drug major Cipla on Tuesday said it has launched a COVID-19 RT PCR testing kit in the country in partnership with diagnostics firm Genes2Me. With the launch of the “RT-Direct multiplex COVID-19 RT PCR” test kit, the Mumbai-based drug firm is expanding…

[goldwingsartsinstitute]

Genes2Me launches molecular biology product range to accelerate bioscience research, Health News, ET HealthWorld

Genes2Me launches molecular biology product range to accelerate bioscience research, Health News, ET HealthWorld

New Delhi: Genomics-focused diagnostic company Genes2Me launched a molecular biology product range to accelerate and support bioscience research under the ‘Made in India’ initiative. The product range contains Fantom-DNA polymerase that can help in precise amplification of target genes in gene-expression studies. The newly launched range includes enzyme technology, cloning, next-generation…

[untitled59750]

Genes2me: Transforming genetics for billions

Genes2me: Transforming genetics for billions

Genes2me is one of the leading clinical genomics & diagnostic entity working with a vision to bring about a meaningful change in molecular, ‘at home’ genetics and personalized medicine space. The start-up is presently recognized as one of the prominent companies leading the molecular diagnostics and manufacturing of the IVD kits segment in India. “Our current focus is on the domains of mother and…

[pathologylab]

#G2M's Rapi-X16 #Automated Nucleic Acid #Extraction System employs magnetic beads separation technology. It utilizes 96-deep well plates and various reagents for purifying clinical samples such as blood, tissue, #viruses, and cells. The #system ensures #temperature uniformity through precise controls. Special magnetic rods are used to absorb, transfer, and release #magnetic beads, facilitating the purification of high-quality #nucleic acid.

Contact us at social@genes2me.com or +91-8800821778 if you need any further assistance!

Visit our website for more information: https://www.genes2me.com/dna-rna-extraction-system

#nucleicacid # #system #instrument #genes2me #technology #tissue #blood #healthcare #facilitating #acid #rtpcr #pcr

[genes2me]

An inherited risk for cancer happens because a person is born with a non-working gene, also known as gene mutation. And when a person is born with gene mutation, it increases their risk of developing specific types of cancers. In India, hereditary cancer sequencing panel use is increasing as more people become aware of the dangers of inheriting cancers from their parents.

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.

[consumerinfoline]

Genes2Me - For the First Time in the World, Driving Innovation by Combining Genetic Testing With Full Body Checkup

Genes2Me – For the First Time in the World, Driving Innovation by Combining Genetic Testing With Full Body Checkup

DELHI, February 18, 2019/PRNewswire/ —

In the crowded preventive health segment space, there are thousands of labs offering routine full body checkups. These packages claim to provide a ‘preventive’ health picture for all individuals. However, these checkups are merely a state of one’s current parameters. In other words, a normal full body checkup report only provides information on some of the…

[pathologylab]

#Circulating tumor #DNA (ctDNA) testing represents a significant advancement in precision oncology. ctDNA refers to small fragments of tumor-derived DNA that are released into the bloodstream as #cancer cells die and disintegrate. Unlike traditional #tissue biopsies, which involve invasive procedures to extract tumor tissue, CtDNA #testing uses a simple blood sample—often termed a "liquid biopsy"—to analyze these fragments.

#G2M CtDNA Lung #Panel screens lung cancer causing genes to identify somatic #mutations in DNA from #blood tissue. It provides comprehensive detail of the cancer and helps to decide the best course of #treatment. The screening method involves using circulating tumor cells that are used as biomarkers to detect lung cancer. Circulating tumor DNA (ctDNA) is released from apoptotic and #necrotic tumor cells. #Applications of ctDNA in lung cancer include early #diagnosis and detection, prognosis prediction, detecting mutations and #structural alterations, minimal residual #disease, tumor mutational burden, and tumor evolution tracking.

Visit our website for more information: https://www.genes2me.com/next-generation-sequencing-clinical-panels/cancer-diagnosis-dna-Panels

#lungcancer #cancerpanel #cell #genes2me #diagnosis #awareness #worldlungday #lungday #worldlungday2024 #lungday2024

[moneyhealthfinance-blog]

Genes2Me- Bringing New Healthcare Paradigm with Genomics Genes2Me, India’s first diagnostic chain to bridge clinical diagnostics with genomics has reinvigorated the preventive healthcare sector in the country.